Monoclonal antibody anti-sclerostin for treatment of pelvic insufficiency fractures in adult hypophosphatasia: A case report
Hypophosphatasia is a rare inherited metabolic disease leading to inhibition of bone and teeth mineralization that can be complicated by multiple insufficiency fractures. Treatment is currently limited to enzyme replacement therapy using bone-targeting recombinant human alkaline phosphatase, or asfo...
Saved in:
| Main Authors: | Pierre-Emmanuel Schwab, Alicia Dessain, Joshua Milby |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-10-01
|
| Series: | Trauma Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352644024001006 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sclerostin and Cardiovascular Risk: Evaluating the Cardiovascular Safety of Romosozumab in Osteoporosis Treatment
by: Shi-Hsun Chiu, et al.
Published: (2024-12-01) -
Neurological and Neurosurgical Aspects of Hypophosphatasia
by: Vadim P. Ivanov, et al.
Published: (2018-07-01) -
Serum sclerostin in vascular calcification in CKD: a meta-analysis
by: Yan Lin, et al.
Published: (2023-12-01) -
Phenotypic and Genotypic Spectrum of Indian Patients with Hypophosphatasia
by: Melkunte S. Dhananjaya, et al.
Published: (2025-03-01) -
Progress of studies on sclerostin’s role in vascular calcification of chronic kidney disease
by: PENG Qiong-yao, et al.
Published: (2019-01-01)